1. Home
  2. HURN vs LGND Comparison

HURN vs LGND Comparison

Compare HURN & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HURN
  • LGND
  • Stock Information
  • Founded
  • HURN 2002
  • LGND 1987
  • Country
  • HURN United States
  • LGND United States
  • Employees
  • HURN N/A
  • LGND 68
  • Industry
  • HURN Professional Services
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • HURN Consumer Discretionary
  • LGND Health Care
  • Exchange
  • HURN Nasdaq
  • LGND Nasdaq
  • Market Cap
  • HURN 2.3B
  • LGND 2.2B
  • IPO Year
  • HURN 2004
  • LGND 1992
  • Fundamental
  • Price
  • HURN $138.73
  • LGND $159.08
  • Analyst Decision
  • HURN Strong Buy
  • LGND Strong Buy
  • Analyst Count
  • HURN 4
  • LGND 8
  • Target Price
  • HURN $171.50
  • LGND $144.71
  • AVG Volume (30 Days)
  • HURN 199.0K
  • LGND 139.7K
  • Earning Date
  • HURN 07-31-2025
  • LGND 08-05-2025
  • Dividend Yield
  • HURN N/A
  • LGND N/A
  • EPS Growth
  • HURN 37.96
  • LGND N/A
  • EPS
  • HURN 5.74
  • LGND N/A
  • Revenue
  • HURN $1,556,665,000.00
  • LGND $181,488,000.00
  • Revenue This Year
  • HURN $11.50
  • LGND $18.41
  • Revenue Next Year
  • HURN $7.48
  • LGND $18.87
  • P/E Ratio
  • HURN $23.58
  • LGND N/A
  • Revenue Growth
  • HURN 9.24
  • LGND 53.40
  • 52 Week Low
  • HURN $102.58
  • LGND $81.74
  • 52 Week High
  • HURN $155.00
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • HURN 60.51
  • LGND 71.61
  • Support Level
  • HURN $134.94
  • LGND $149.51
  • Resistance Level
  • HURN $136.99
  • LGND $155.28
  • Average True Range (ATR)
  • HURN 3.42
  • LGND 6.09
  • MACD
  • HURN 0.89
  • LGND 0.39
  • Stochastic Oscillator
  • HURN 98.11
  • LGND 90.41

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: